Interaction between medicines and medicinal plants;Interacción entre fármacos y plantas medicinales

Anales del Sistema Sanitario de Navarra

Volumn 29, Issue 2, 2006, Pages 233-252

  Tres, J C ^a,b  

^a Centro de Farmacovigilancia de Navarra   (Spain)

^b Universidad Pública de Navarra   (Spain)

Author keywords

Herbal medicine; Interactions; Interactions with medicines; Medicinal plants

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIANEMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; CANNABIS; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINESTERASE INHIBITOR; DIGOXIN; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM EXTRACT; HYPNOTIC AGENT; IMMUNOMODULATING AGENT; ISPAGULA; KAVA EXTRACT; NEUROLEPTIC AGENT; PLANT EXTRACT; PRIMROSE OIL; TRANQUILIZER;

ADJUVANT THERAPY; ALLOPATHY; BETEL NUT; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENTIATION; EVENING PRIMROSE; GARLIC; GINKGO BILOBA; GINSENG; HUMAN; HYPERICUM; MEDICAL LITERATURE; MEDICINAL PLANT; PIPER METHYSTICUM; PLANTAGO; REVIEW;

HERB-DRUG INTERACTIONS; HUMANS;

EID: 33750092254     PISSN: 11376627     EISSN: 11376627     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. WINSLOW LC, KROLL DJ. Herbs as medicines. Arch Intern Med 1998; 158: 2192-2199.
2. EISENBERG DM, DAVIS RB, ETTNER S, APPEL S, WILKEY S, VAN ROMPAY M et al. Trends in alternative medicine use in the United States. Results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
3. ERNST E. Herbal medicines: where is the evidence? Growing evidence of effectiveness is connterbalanced by inadequate regulation. Br Med J 2000; 321: 395-396.
4. SANFELIX J, PALOP V, RUBIO E, MARTINEZ-MIR I. Consumo de hierbas medicinales y medicamentos. Aten Prim 2001; 28: 311-314.
5. DEVESA F, PELLICER J, FERRANDO J, BORGHOL A, BUSTAMANTE M, ORTUÑO J et al. Consumo de hierbas medicinales en los pacientes de consultas externas de digestivo. Gastroenterol Hepatol 2004; 27: 244-249.
6. VALENCIA O, ORTS A, CASTELLS MV, PÉREZ-CERDÁ F. Valoración del consumo preoperatorio de plantas medicinales en la consulta preanestésica. Rev Esp Anestesiol Reanim 2005; 52: 453-458.
7. YUE Q-Y, BERGQUIST C, GERDEN B. Safety of St. John's wort (Hypericum perforatum). Lancet 2000; 355: 576-577.
8. DONATH F, ROOTS I, LANGHEINRICH M. Interaction of St. John's wort extract with phenprocoumon. Eur J Clin Pharmacol 1999; 55: A22.
9. Monitoring the safety and quality of Medicines. Herbal safety news. St. John's wort [on line]. Avaible from URL: http://medicines.mhra.gov.uk.
10. MAKINO T, WAKUSHIMA H, OKAMOTO T, OKUKUBO Y, SAITO K, KANO Y. Pharmacokinetic interactions between warfarin and Kangen-Karyu, a chinese traditional herbal medicine, and their synergistic action. J. Ethnopharmacol 2002; 82: 35-40.
11. PAGE RL, LAWRENCE JD. Potentiation of warfarin by Dong Quai. Pharmacotherapy 1999;19: 870-876.
12. YU CM, CHAN JCN, SANDERSON JE. Chinese herbs and warfarin potentiation by "Danshen". J Int Med 1997; 241: 337-339.
13. TAM LS, CHAN TYK, LEUNG WK, CRITCHLEY JA. Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Aust Nz J Med 1995; 25: 258.
14. CHAN TYK. Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving warfarin. Int J Clin Pharmacol Ther 1998; 36 (7):403-405.
15. VAES LP, CHYKA PA. Interactions of warfarin with garlic, ginger, ginkgo or ginseng: nature of the evidence. Ann Pharmacoter 2000; 34: 1478-1482.
16. MOHAMMAD SF, WOODWARD SC. Characterization of a potent inhibitor of platelet aggregation and release reaction isolated from Allium sativum (garlic). Thromb Res 1986; 44: 793-806.
17. LAWSON LD, RANSON DK, HUGHES BG. Inhibition of whole blood platelet-aggregation by componuds in garlic clove extracts and commercial garlic products. Thromb Res 1992; 65: 141-156.
18. SUNTER W. Warfarin and garlic. Pharm J 1991: 722.
19. DORSO CR, LEVIN RJ, ELDOR A, JAFFE EA, WEKSLER BB. Chinese food and platelets (letter). N Eng J Med 1980; 303: 756-757.
20. MATTEWS MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998; 50: 1933-1934.
21. JANETZKY K, MORREALE AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692-693.
22. YUAN C-S, WEI G, DEY L, KARRISON T, NAHLIK L, MALECKAR S et al. Brief communication: American Ginseng reduces warfarin's effect in healthy patients. Ann Intern Med 2004; 141: 23-27.
23. LAM AY, ELMER GW, MOHUTSKY MA. Possible interaction between warfarin and Lycium barbarum. Ann Pharmacother 2001; 35: 1195-1199.
24. LAMBERT JP, CORMIER A. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy 2001; 21: 509-512.
25. YUE Q-Y, JANSSON K. Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component [letter]. J Am Geriatr Soc 2001; 49: 838.
26. ROBINSON DS, BENJAMIN DM, MCCORMACK JJ. Interaction of warfarin and non-systemic gastrointestinal drugs. Clin Pharmacol Ther 1971; 12: 491-495.
27. MONTERREY-RODRIGUES J, FELIU JF, RIVERA-MIRANDA GC. Interaction between warfarin and mango fruit. Ann Pharmacother 2002; 36: 940-941.
28. TAYLOR JR, WILT VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999; 33: 426-428.
29. MILLER LG, MURRAY WJ EDITORS. Herbal medicinals: a clinician's guide. New York. Pharmaceutical Products Press. 1998.
30. ROWIN J, LEWIS SL. Spontaneous bilateral subdural hematomas associated with chronic ginkgo. Neurology 1996; 46: 1775-1776.
31. CHUNG KF, MCCUSKER M, PAGE CP, DENT G, GUINOT P, BARNES PJ. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet reponses to platelet activating factor in man. Lancet 1987; 1: 248-251.
32. BARNES J, PHILLIPSON JD, ANDERSON LA. Herbal medicines. 2nd ed. London: The Pharmaceutical Press, 2002.
33. PATHAK A, LEGER P, BAGHERI H, SENARD J-M, BOCCALON H, MONTASTRUC J-L. Garlic interaction with fluindione a case report. Therapie 2003; 58(4): 380-381.
34. ROSENBLATT M, MINDEL J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 338: 1108.
35. MATTHEWS MK. Association of ginkgo biloba with intracerebral haemorrhage. Neurology 1998; 50: 1933-1934.
36. VALE S. Subarachnoid hemorrhage associated with Ginkgo biloba. Lancet 1998; 352 (912): 36.
37. JOHNE A, BRÖCKMOLLER J, BAUER S, MAURER A, LANGHEINRICH M, ROOTS I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338-345.
38. MC RAE S. Elevated serum digoxin levels in a patient taking digoxin and siberian ginseng. Can Med Assoc J 1996;155: 293-295.
39. AWANG DV. Siberian ginseng toxicity may be a case of mistaken identity [letter]. Can Med Assoc J 1996; 155: 1237.
40. TRUNZLER G, SCHULER E. Comparative studies on the effects of a Crataegus extract, Digitoxin, Digoxin and q-strophantin in the isolated heart of Homoiothermals. Azzneim-Forsch 1962: 198-202.
41. TANKANOW R, TAMER HR, STRETMAN DS, SMITH GS, WELTON JL, ANNESLEY T et al. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 2003; 43(6): 637-642.
42. KIM YI, PAIK YH, KANG SS, KIM JH. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits. Arch Int Pharm Ther 1982; 257: 66-76.
43. IMAI Y, NOLAN PL, JOHNSTON CI. Tachycardic and hypertensive effects of centrally adminestered clonidine in concious rats. Clin Exp Hypertension-A Theory & Pract. 1986; 8: 239-258.
44. DE SMET PAGM, KELLER K, HANSEL R. Adverse Effects of Herbal Drugs, vol. 3, Springer-Verlag, Berlin 1997.
45. MUSSO NR, VERGASSOLA C, PENDE A, LOTTI G. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens 1995; 8: 565-571.
46. GROSSMAN E, ROSENTHAL T, PELEG E, HOLMES C, GOLDSTEIN DS. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol 1993; 22: 22-26.
47. SHINOZUKA K, UMEGAKI K, KUBOTA Y, TANAKA N, MIZUNO H, YAMAUCHI J et al. Feeding of Ginkgo biloba extract (GBE) enhances gene expression hepatic cytochrome P-450 and attenuates the hypotensive effects of nicardipine in rats. Life Sci 2002; 70: 2783-2792.
48. WENK M, TODESCO L, KRÄHENBÜHL S. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltranferase 2, and xanthine oxidase in healthy males and females. Br J Clin Pharmacol 2004; 57: 495-499.
49. WANG Z, GORSKI C, HAMMANM, HUANG S-M, LESKO LJ, HALL SD. The effects of St John's wort (Hypericum perforatum) on human cythochrome P450 activity. Clin Pharmacol Ther 2001; 70: 317-326.
50. MARKOWITZ JS, DONOVAN JL, DE VANE CL, TAYLOR RM, RUAN Y, WANG J-S et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290: 1500-1504.
51. MCCOUBRIE M. Doctors as patients: lisinopril and garlic [letter]. Br J Gen Pract 1996; 46: 107.
52. HAKAS JF. Topical capsaicin induces cough in patient receiving ACE inhibitor. Ann Allergy 1990; 65: 322-323.
53. SUGIMOTO K, OHMORI M, TSURUOKA S, NISHIKI K, KAWAGUCHI A, HARADA K-I et al. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001; 70: 518-524.
54. KAYE AD, CLARKE RC, SABAR R, VIG S, DAWAN KP, HOFBAUER et al. Herbal medicines: current trends in anesthesiology practice: a hospital survey. J Clin Anesth 2000; 12(6): 468-471.
55. SABAR R, KAYE AD, FROST EA. Peri-operative considerations for the patient on herbal medicines. Midde Fast J Anesthesiol 2001; 16: 287-314.
56. Monitoring the safety and quality of medicines. Herbal safety news. MHRAs report on the safety of herbal medicinal products (online). Disponible en: http://medicines.mhra.gov.uk
57. KAM PC, LIEW S. Traditional chinese herbal medicine and anaesthesia. Anaesthesia 2002; 57: 1083-1089.
58. HARDER S, KLINKHARDT U. Thrombolytics: drug interactions of clinical significance. Drug Saf 2000; 23 (5): 391-399.
59. ABEBE W. Herbal medication: potential for adverse interactions with analgesic drugs. J. Clin Pharm Ther 2002; 27: 391-401.
60. MUSTAPHA A, YAKASAI IA, AGUYE IA. Effect of Tamarindus indica L. on the bioavailability of aspirin in healthy human volunteers. Eur J Drug Metab Pharmacokinet 1996; 21: 223-226.
61. HOFFMANN T. Ginkgo. Vioxx and excesive bleeding: posible drug interactions: case report (letter). Hawaii Med J 2001; 60: 290.
62. ALMEIDA JC, GRIMSLEY EW. Coma from the health food store: interaction between kava and alprazolam. Ann Int Med 1996; 125(11): 940.
63. HOLMAN CP, BELL AFJ. A trial of evening primrose oil in the treatment of chronic schizophrenia. J Orthomol Psychiatry 1983; 12: 302-304.
64. MIKKELSON EJ, Caffeine and schizofrenia. J Clin Psychiatry 1978; 39: 732-733.
65. CHEESEMAN MJ, NEAL MJ. Interaction of chlorpromazine with tea and coffee. Br J Clin Psychopharmacol 1981; 12: 165-169.
66. BOWENS, TAYLOR KM, GIBB IAM. Effect of coffee and tea on blood levels and efficacy of antipsychotic drugs. Lancet 1981; I: 1217-1218.
67. TOUTONG M, SCHULTZ P, WIDMER J. Probable interaction entre le psyllium et le lithium. Therapie 1990; 45: 357-360.
68. PYEVICH D, BOGENSCHUTZ MP. Herbal diuretics and lithium toxicity. Am J Psychiatry 2001; 158(8):1329.
69. BARBENEL DM, YUSUFI B, O'SHEA D, BENCH CJ. Mania in a patient receiving testosterone replacement post-orchidectomy taking St. John's wort and sertraline. J Psychopharmacol 2000; 14: 84-86.
70. MARKOWITZ JS, DE VANE CI, BOULTON DW, CARSON SW, NAHAS Z, RISCH SC. Effect of St. John's wort (Hypericum perforatum) on cytochrome P 450 2D6 and 3A4 activity in health volunteers. Life Sci 2000; 66: 133-139.
71. ESSOR AH. Clinical observations on reserpine reversal after prolonged MAO inhibition. Psychiatr Neurol Neurochir 1967; 70: 59-63.
72. JONES BD, RUNIKIS AM. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987; 7: 201-202.
73. STOLL AL, COLE JO, LUKES SE. A case of mania as a result of fluoxetine-marijuana interaction. J Clin Psychiatry 1999; 52: 280-281.
74. GALLUZI S, NANETTI O, BINETTI G, TRABUCCHI M, FRISONI GB. Coma in a patient with Alzheimer's disease taking low-dose trazodone and Ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679-683.
75. ROOTS I, JOHNE A, SCHMIDER I. Interaction of a herbal extract from St John's wort with amitriptyline and its metabolites. Clin Pharmacol Ther 2000; 67:159.
76. JOHNE A, SCHMIDER J, BROCKMÖLLER J, STADELMANN AM, STÖRMER E, BAUER S et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John's wort (Hypericum perforatum). J Clin Psychopharmacol 2001; 22: 46-54.
77. AMSTERDAM JD, BERWISH N. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy. J Clin Psychopharmacol 1987; 7: 238-242.
78. HOLMBERG G, GERSHOW S. Autonomic and psychic effects of Yohimbine hydrochloride. Psychopharm 1961; 2: 93-106.
79. LACOMBLEZ L, BENSIMON G, ISNARD F, DIQUET B, LECRUBIER Y, PUECH AJ. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clormipramine. Clin Pharmacol Ther 1989; 45: 241-251.
80. CHARNEY DS, PRICE LM, HENINGER GR. Desipramine-Yohimbine combination treatment of refractory depression. Arch Gen Psychiatry 1986; 43: 1155-1161.
81. STOCKLEY IH, editor. Stockley's drug interactions. 6th ed. London: The Pharmaceutical Press, 2002.
82. SCHELOSKY L, RAFFAUF C, JENDROSKA K, POEWE W. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 1995; 58(5): 639-640.
83. DEAHL M. Betel nut induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord 1989; 4: 330-333.
84. BURSTEIN AH, HORTON RL, DUNN T, ALFARO RM, PISCITELLI SC, THEODORE W. Lack of effect of St. John's wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 2000; 68: 605-612.
85. SPINELLA M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2001; 2: 524-532.
86. RIEDEL E, HANSEL R, EHRKE G. Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives. Planta Med 1982; 46: 219-220.
87. LEUCHNER J, MULLER J, RUDMANN M. Characterisation of the central nervous system depressant activity of a commercially available valerian root extract. Arznemittel Forschung 1993; 43: 44-47.
88. MEDINA JH, VIOLA H, WOLFMAN C, MARDER M, WASOWSKI C, CALVO D et al. Overview: flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 1997; 22: 419-425.
89. AULT B, OLNEY MA, JOYNER JL, BOYER CE, NOTRICA MA, SOROKO FE et al. Proconvulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Res 1987; 426: 93-102.
90. BURKHARD PR, BURKHARD K, HAENGGELI CA, LANDIS T. Plant-induced seizures: reappearance of an old problem. J Neurol 1999; 246: 667-670.
91. TISSERAND R, BALACS T. Essential oil safety. Edinburgh: Churchill Livingstone, 1995.
92. MIWA H, IJIMA M, TANAKA S, MIZUNO Y. Generalized convulsions after consuming a large amount of ginkgo units. Epilepsia 2001; 42: 280-281.
93. KAJIYAMA Y, FUJII K, TAKEUCHI H, MANABE Y. Ginkgo seed poisoning. Pediatrics 2002; 109: 325-327.
94. GREGORY PJ. Seizure associated with Ginkgo biloba? Ann Intern Med 2001;134:344.
95. GRANGER AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001; 30: 523-525.
96. HENNESSY M, KELLEHER D, SPIERS JP, BARRY M, KAVANAGH P, BACK D et al. St John's wort increases expression of P glycoprotein: implications for drug interactions. Br J Chin Pharmacol 2002; 53: 75-82.
97. HENDERSON L, YUE QY, BERGQUIST C, GERDEN B, ARLETT P. St John's wort (Hypericum perforatum): drug interactions and clinical outcome. Br J Clin Pharm 2002; 54: 349-356.
98. MURPHY PA. St John's wort and oral contraceptives: reasons for concern?. J Midwifery Womens Health 2002; 47: 447-450.
99. PFRUNDER A, SCHLESSER M, GERBER S, HASCHKE M, BITZER J, DREWE J. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 2003; 56: 683-690.
100. HALL S, WANG Z, HUANG S-M, HAMMAN MA, VASAVADA N, ADIGUN AQ et al. The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 2003; 74: 525-535.
101. BOYLE FM. Adverse interaction of herbal medicine with breast cancer treatment (letter). Med J Aust 1997; 167: 286.
102. ISHIHARA K, KUSHIDA H. YUZURIHARA M, WAKUI Y, YANAGISAWA T, KAME T et al. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diacepam caused by extract of Angelica dahurica. J Pharm Pharmacol 2000; 52: 1023-1029.
103. ASLAM M, STOCKLEY IH. Interaction between curry ingredient (Karela) and drug (Chlorpropamide) (letter). Lancet 1979; 5.
104. SOTANIEMI EA, HAAPAKOSKI E, RAUTIO A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18(10): 1373-1375.
105. ZHOU M, WONG PYK, LI RC. Effect of oral administration of fennel (Foeniculum vulgare) in ciprofloxacin absortion and disposition in the rat. J Pharm Pharmacol 1999; 51: 1391-1396.
106. ABDEL GHANI YM, ETMAN MA, NADA AH. Effect of khat chewing on the absortion of orally administered amoxicillin. Acta Pharm 1999; 49: 43-50.
107. HUUPPONEN R, SEPPÄLA P, IISALO E. Effect of guar gum, a fibre preparation, on digoxin and penicillin absortion in man. Eur J Clin Pharmacol 1984; 26: 279-281.
108. PISCITELLI SC, BURSTEIN AH, CHAITT D, ALFARO RM, FALLOON J. Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-548.
109. PISCITELLI SC, BURSTEIN AH, WELDEN N, GALLICANO KD, FALLOON J. The effects of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2001; 34: 234-238.
110. GALLICANO K, FOSTER B, CHOUDHRI S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003; 55: 199-202.
111. Anonimous. Garlic supplements can impede HIV medication. J Am Coll Surg 2004; 194: 251.
112. BREIDENBACH T, KLIEM V, BURG M, RADERMARCHER J, HOFFMANN MW, KLEMPNAUER J. Profound drop of cyclosporin. A whole blood trough levels caused by St. John's wort (Hypericum perforatum). Transplantation 2000; 69: 2229-32.
113. BREIDENBACH T, HOFFMAN MW, BECKER T, SCHLITT M, KLEMPNAUER J. Drug interaction of St. John's wort with ciclosporin [letter]. Lancet 2000; 355: 1912.
114. BAUER S, STÖRMER E, JOHNE A, KRÜGER H, BUDDE K, NEUMAYER H-H et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 2003; 55: 203-211.
115. RUSCHITZKA F, MEIER PJ, TURINA M, LÜSCHER TF, NOLL G. Acute heart transplant refection due to St. John's wort. Lancet 2000; 355: 548-549.
116. BARONE GW, GURLEY BJ, KETEL BL, ABUL-EZZ SR. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001; 71: 239-241.
117. AHMED SM, BANNER NR, DUBREY SW. Low cyclosporin-A level due to St John's wort in heart transplant patients [letter]. J Heart Lung Transplant 2001; 20: 795.
118. HEBERT MF, PARK JM, CHEN Y-L, AKHTAR S, LARSON AM. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004; 44: 89-94.
119. MAI I, STÖRMER E, BAUER S, KRÜGER H, BUDDE K, ROOTS I. Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 2003; 18: 819-822.
120. DUCLOS J, GOECKE H. "Hierba del clavo" (Geum chiloense) interfiere niveles de ciclosporina: potencial riesgo para transplantados. Rev Med Chil 2001; 129: 789-790.
121. CHEN M-F, SHIMADA F, KATO H, YANO S, KANAOKA M. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn 1991; 38: 167-174.
122. BLOCK KI, GYLLEN HAAL C. Clinical corner: herb drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integrative Cancer Ther 2002; 1: 83-89.
123. MATHIJSSEN RHJ, VERWEIJ J, DE BRUIJN P, LOOS J, SPARREBOOM A. Effects of St John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94: 1247-1249.
124. SMITH PF, BULLOCK JM, BOOKER BM, HAAS CE, JUSKO WJ. The influence of St. John's Wort on the pharmacokinetics and protein imatinib mesylate. Pharmacotherapy 2004; 24: 1508-1514.
125. MENENDEZ JA, ROPERO S, BARBACID M, MONTERO S, SOLANAS M, ESCRICH E et al. Synergistic action between vinorelbine and gamma-linolenic acid in human breast cancer cell lines. Breast Cancer Res Treat 2002; 72: 1-17.
126. HENDERSON L, YUE QY, BERGQUIST C, GERDEN B, ARLETT P. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes Br J Clin Pharm 2002:54:349-56.
127. NEBEL A, SCHNEIDER BJ, BAKER RK, KROLL DJ. Potential metabolic interaction between St John's wort and theophylline. Ann Pharmacother 1999; 33: 502.
128. MORIMOTO T, KOTEGAWA T, TSUTSUMI K, OHTANI Y, IMAI H, NAKANO S. Effect of St John's wort on the pharmacokinetics of theophylline in healthy volunteers. J Clin Pharmacol 2004; 44: 95-101.
129. WILLIAMSON E. Sinergy and other interactions in phytomedicines. Phytomedicine 2001; 8: 401-409.
130. MCLEOD AL, MCKENNA CJ, NORTHRIDGE DB. Sildenafil: first report of an interaction with concomitant marijuana leading to myocardial infartion: case report [short comunication]. Via Reactions 2002; 900, 11.
131. VALLI G, GIARDIANA EG. Benefits, adverse effects and drug interactions of herbal therapics with cardiovascular effects. J Am Coll Cardiol 2002; 38: 1083-1095.
132. MANSOOR G. Herbs and alternative therapies in the hypertension clinic. Am J Hypertens 2002; 14: 971-975.
133. WANG L-S, ZHOU G, ZHU B, WU J, WANG J-G, ELATY AMA et al. St John's wort induces both cytochrome P4503A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 2004; 75: 191-197.
134. WANG Z, HAMMAN M, HUANG S-M, LESKO LJ, HALL SD. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71: 414-420.
135. SIKORA R, SOHN M, DEUTZ FJ, BOHNDORF K. Ginkgo Biloba extract in the therapy of erectile dysfunction. J Urol 1989; 141: 188A.